Skip to main content

Critical Care Reviews Newsletter

Newsletter 474  |  January 11th 2021

Welcome to the 474th Critical Care Reviews Newsletter, bringing you the best critical care research and open access articles from across the medical literature over the past seven days. It's a small newsletter as it's the week before the annual meeting, and I have limited time to put this together.

The highlights of this week's edition are four randomised controlled trials: firstly, the preprint of the REMAP-CAP IL-6 receptor anatgonists domain; secondly, another tocilizumab trial, this time in a more general population of patients hospitalized with Covid-19 pneumonia; thirdly, early high-titer plasma therapy to prevent severe Covid-19 in older adults; and finally, pulsed intravenous methylprednisolone in patients hospitalised with severe COVID-19.

There will be lots of activity around the meeting this week, starting with the release of the programme tonight. Registration, the release of the livestream url and other information is also due imminently.

 

Randomised Controlled Articles

Systematic Reviews & Meta Analyses

Observational Studies

Clinical

COVID-19

Neurological

Circulatory

Respiratory

Metabolic

Sepsis

Paediatrics

Non-Clinical

Until next week

Rob